aegeline,
N-(2-hydroxy-2(4-methoxyphenyl)ethyl)-3-phenyl-2-propenamide,
Aegelin,
456-12-2,
AEGELINE,
N-(2-Hydroxy-2-(4-methoxyphenyl)ethyl)cinnamamide,
(+-)-Aegeline,
(+-)-Egeline,
N-[2-Hydroxy-2-(4-methoxyphenyl)ethyl]cinnamamide,
AK142226,
(+/-)-Aegeline,
MEGxp0_001339,
ACon1_000768,
7162AJ,
MFCD00048045,
N-(2-Hydroxy-2(4-methoxyphenyl)ethyl)-3-phenyl-2-propenamide, (E)-,
AKOS022174795,
CS-W022896,
RL03710,
NCGC00169378-01,
AX8282099,
ST2413544,
N-CinnaMoyl--hydroxy-4-Methoxyphenyl-aethylaMin,
N-Cinnamoyl-?-Hydroxy-4-methoxyphenyl-aethylamin,
J-523534,
BRD-A95848471-001-01-3,
(E)-N-[2-Hydroxy-2-(4-methoxyphenyl)ethyl]cinnamamide,
(2E)-N-[2-hydroxy-2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enamide,
2-Propenamide, N-(2-hydroxy-2-(4-methoxyphenyl)ethyl)-3-phenyl-, (E)-,
NCGC00169378-02!(E)-N-[2-hydroxy-2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enamide,
UNII-60T59LN3SG,
60T59LN3SG,
C18H19NO3,
CS-O-10919,
A3170,
C560978,
N-(2-hydroxy-2(4-methoxyphenyl)ethyl)-3-phenyl-2-propenamide,